康弘药业
(002773)
| 流通市值：134.35亿 | | | 总市值：180.21亿 |
| 流通股本：6.87亿 | | | 总股本：9.21亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,425,314,458.64 | 3,421,868,627.97 | 6,273,956,852.19 | 6,435,444,571.76 |
| 交易性金融资产 | 2,969,000,000 | 2,919,000,000 | 440,000,000 | - |
| 应收票据及应收账款 | 275,401,556.05 | 288,116,814.34 | 203,838,994.03 | 189,097,202.93 |
| 其中：应收票据 | 1,011,200 | 1,200,000 | 1,200,000 | - |
| 应收账款 | 274,390,356.05 | 286,916,814.34 | 202,638,994.03 | 189,097,202.93 |
| 预付款项 | 89,079,003.34 | 67,515,158.55 | 63,322,685.33 | 12,722,163.96 |
| 其他应收款合计 | 10,123,584.11 | 4,404,376.88 | 8,894,421.72 | 4,407,216.13 |
| 存货 | 413,186,363.14 | 405,203,970.03 | 412,536,518.62 | 407,046,032.98 |
| 其他流动资产 | 52,680,594.69 | 47,766,406.13 | 36,774,124.95 | 35,743,387.12 |
| 流动资产合计 | 7,234,785,559.97 | 7,153,875,353.9 | 7,439,323,596.84 | 7,084,460,574.88 |
| 非流动资产: | | | | |
| 长期股权投资 | 15,282,408.79 | 15,383,483.78 | 15,579,582.85 | 15,794,362.62 |
| 固定资产 | 2,100,644,158.11 | 2,146,922,528.41 | 2,177,431,484.31 | 2,148,397,606.27 |
| 在建工程 | 35,331,768.95 | 29,128,436.84 | 34,108,974.26 | 97,561,580.51 |
| 生产性生物资产 | 2,015,609.96 | 1,359,392.99 | 3,563,717.61 | 3,868,770.06 |
| 使用权资产 | 1,587,974.38 | 2,643,249.32 | 3,086,027.92 | 3,531,441.19 |
| 无形资产 | 333,378,627.23 | 341,224,232.25 | 343,216,239.74 | 352,925,457.52 |
| 开发支出 | 189,266,527.41 | 132,406,692.69 | 78,687,513.37 | 60,665,923.49 |
| 长期待摊费用 | 797,410.01 | 904,717.2 | 950,955.1 | 1,089,988.01 |
| 递延所得税资产 | 95,070,280.43 | 103,015,983.23 | 97,775,247.41 | 128,853,449.18 |
| 其他非流动资产 | 49,408,606.63 | 12,232,335.44 | 15,797,978.66 | 22,715,590.94 |
| 非流动资产合计 | 2,822,783,371.9 | 2,785,221,052.15 | 2,770,197,721.23 | 2,835,404,169.79 |
| 资产总计 | 10,057,568,931.87 | 9,939,096,406.05 | 10,209,521,318.07 | 9,919,864,744.67 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 159,744,739.04 | 189,755,873.23 | 179,334,233.4 | 221,431,323.18 |
| 应付账款 | 159,744,739.04 | 189,755,873.23 | 179,334,233.4 | 221,431,323.18 |
| 预收款项 | 52,307.19 | 3,409,628.6 | 1,488,948.33 | 2,753,079.52 |
| 合同负债 | 4,498,414.43 | 9,333,203.26 | 16,527,058.41 | 2,061,455.33 |
| 应付职工薪酬 | 21,242,118.44 | 21,656,942.9 | 25,727,776.39 | 122,005,315.31 |
| 应交税费 | 104,215,105.56 | 95,725,968.77 | 78,755,411.35 | 54,763,454.72 |
| 其他应付款合计 | 285,193,386.72 | 348,726,647.58 | 139,474,440.45 | 46,206,559.73 |
| 应付股利 | - | 145,408,493.3 | - | - |
| 一年内到期的非流动负债 | 346,781.4 | 1,549,225.14 | 1,290,930.8 | 1,684,628.13 |
| 其他流动负债 | 43,740,984.06 | 42,829,918.69 | 143,331,131.29 | 150,810,909.96 |
| 流动负债合计 | 619,033,836.84 | 712,987,408.17 | 585,929,930.42 | 601,716,725.88 |
| 非流动负债: | | | | |
| 租赁负债 | 1,076,227.61 | 598,123.19 | 911,583.56 | 1,822,568.74 |
| 长期应付款 | 3,972,340.34 | 5,172,919.88 | 4,816,077.75 | 5,384,296.52 |
| 递延收益 | 28,082,521.29 | 28,882,080.15 | 29,681,639.01 | 26,712,864.53 |
| 递延所得税负债 | 10,546,058.62 | 10,661,998 | 10,057,103.62 | 9,580,383.15 |
| 非流动负债合计 | 43,677,147.86 | 45,315,121.22 | 45,466,403.94 | 43,500,112.94 |
| 负债合计 | 662,710,984.7 | 758,302,529.39 | 631,396,334.36 | 645,216,838.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 921,326,354 | 921,326,354 | 921,320,954 | 921,320,954 |
| 资本公积 | 2,028,428,984.16 | 2,028,428,984.16 | 2,030,612,371.79 | 2,030,612,371.79 |
| 其他综合收益 | -3,199,244.9 | -3,147,479.57 | -1,180,292.83 | -1,454,006.96 |
| 盈余公积 | 515,315,206.97 | 515,315,206.97 | 515,315,206.97 | 515,315,206.97 |
| 未分配利润 | 5,972,249,207.96 | 5,752,939,750.29 | 6,140,604,094.78 | 5,833,121,960.34 |
| 归属于母公司股东权益合计 | 9,434,120,508.19 | 9,214,862,815.85 | 9,606,672,334.71 | 9,298,916,486.14 |
| 少数股东权益 | -39,262,561.02 | -34,068,939.19 | -28,547,351 | -24,268,580.29 |
| 股东权益合计 | 9,394,857,947.17 | 9,180,793,876.66 | 9,578,124,983.71 | 9,274,647,905.85 |
| 负债和股东权益合计 | 10,057,568,931.87 | 9,939,096,406.05 | 10,209,521,318.07 | 9,919,864,744.67 |
| 公告日期 | 2026-10-28 | 2026-08-26 | 2026-04-23 | 2026-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |